Showing 1 - 2 results of 2 for search 'Tongjuan Li', query time: 0.01s Refine Results
  1. 1
    CAR T-cell therapy for relapsed/refractory CD5-positive diffuse large B-cell lymphoma yields more favorable outcomes than standard therapy

    CAR T-cell therapy for relapsed/refractory CD5-positive diffuse large B-cell lymphoma yields more favorable outcomes than standard therapy by Hui Luo, Tongjuan Li, Fankai Meng, Zhenya Hong, Yang Cao, Gaoxiang Wang, Liang Huang, Xiaoxi Zhou

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma

    Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma by Hanyu Wang, Gaoxiang Wang, Tongjuan Li, Peiling Zhang, Zekai Mao, Hui Luo, Xiaojian Zhu, Dengju Li, Jianfeng Zhou, Xiaoxi Zhou, Liang Huang

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: